Pediatric Oncology Fellowship
Program ID
- Program Name: Pediatric Oncology Fellowship
- Program Description: The program curriculum use the American Academy of Pediatrics Oncology curriculum as a guide. Training is centered primarily on CCHE with formal collaboration with DF/BC.
- Track 1: is a 36-month fellowship in general pediatric oncology.
- Track 2: is a 12-month sub-specialty option for pediatric oncologists to develop expertise in a variety of pediatric oncology subspecialties.
- Track 3: is a 24-month subspecialty focus that would be available to other non-pediatric oncology specialists to develop expertise in a variety of pediatric oncology related subspecialties.
- Collaboration Dana-Farber Boston Children’s Cancer and Blood Disorders Center.
- Degree /Certificate: Training Certificate from the CCHF 57357 and DF/BC.
- Duration: Program duration is 36 months inclusive of vacation time (3 weeks per year in the first two years).
- Location: Based at CCHE Cairo, Egypt with a rotation to DFBC in Boston MA, USA. Other affiliated hospitals or institutions in the USA may also participate in the program.
- Mode of Delivery: On-Site live training.
- Program Content Model: Course content is set using the American Academy of Pediatric Oncology curriculum guidelines.
The program comprises a three-track option with the express purpose of increasing the number and skill level of pediatric oncologists as well as pediatric oncology sub-specialists in Egypt and the region.
The collaboration initiative is a joint effort between CCHF 57357 and DF/BC. The program is made up of three tracks:
2020-2021 Review
- Number of Applicants: 12 Applicant.
- Short list: 9 Applicant.
- Selection Process Outcome “No. of participants”: 4 Fellows.
- No. of External Candidates: 0
- Participants Scientific Activities:
- Weekly Lectures.
- Study team meetings CCHE.
- Combined clinics CCHE (50%).
- Mortality and morbidity rounds CCHE.
- Visiting lecturers.
- Monthly video conferencing of difficult cases at both institutions.
- DFBC tumor board and other appropriate joint tutorial sessions.
- Assignments.
- International Visits
- 1st Visit: April 2021 , “Dr. Leslie Liehman, Dr. Liliana Gomrinova & Dr. Mark Keirn”
- Visit Duration: 4 days (4th & 7th January 2020)
- Visit Goal:
- Clinical rounds.
- Research project follow-up.
- Committee meeting.
- PNOC Meeting.
- Case presentations.
- Visit Outcome: revising research projects, training the fellows how to make a clinical presentation on any case, the fellows presented cases and discuss with the committee about its treatment plan.
- 2nd Visit: July 2021 “Dr. Leslie Lehman, Dr. Liliana Gomrinova & Dr. Mark Keirn”
- Visit Duration: 4 days (4th to 7th July 2021)
- Visit Goals:
- Fellow’s assessment and evaluation.
- Written final exam for fellows 2018.
- OSCE exam for fellows 2018.
- Interviewing new applicants.
- Finalize selection process results and select the new patch 2021.
- Project discussions.
- Visit Outcome:
- Patch 2021 selection.
- Final exam for fellows 2018.
- Projects tracking.
- Followup fellows activities.
- Visit Duration: 4 days (31st of October, 2021 to 3rd of November, 2021)
- Visit Goals:
- Committee Meetings for revising all the fellows’ activities.
- Revising all the projects of the fellows from 2015 to 2020.
- Visit Outcome:
- Following the fellows’ activates.
- Revising all the projects' progress for 6 Patches.
- Participant Projects Sheet: *in appendix 1
- Publication Project: *in appendix 1
- Pass Rate (No. of successful candidates/Total no of candidates): 100%
Visitors: 2021 visits From Boston team. (3 visits)
3rd Visit: “Dr. Mark Kiern, DR Lei sly Lehman, and Dr. Liliana Joumnerova”
Publication Project
Pediatric Oncology Fellowship Research Projects
Published Projects
Fellow Name | Class | Project title | Journal Name | Publication link | Impact Factor |
Hisham Moneib | 2014 | Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children with Hematologic Malignancies. | (Clinical Lymphoma, Myeloma and leukemia) 2019 | https://www.clinical-lymphoma-myeloma- leukemia.com/article/ S21 52-2650(18)30585-8/fulltext | 2.29 |
Noura Mahmoud | 2014 | Outcome of Childhood Acute Megakaryoblastic Leukemia: Children’s Cancer Hospital Egypt 57357 Experience. | (Clinical Lymphoma, Myeloma and leukemia) 2018 | https://www.clinical-lymphoma-myeloma- leukemia.com/article/ S21 52-2650(18)30585-8/fulltext | |
Ahmed Emad | 2015 | Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma. | (Pediatric Hematology Oncology. 2019) | https://journals.lww.com/jpho-online/ Abstract/2020/03000/ Outcome_of_Children_Treated_ for_Infantile_Hepatic.7.aspx | 0.947 |
Ahmed Mahdy | 2015 | Incidence, risk factors, and outcome of blood stream infections during the first 100 days post‐pediatric allogeneic and autologous hematopoietic stem cell transplantations | (Pediatric transplantation, 2019) | https://onlinelibrary.wiley.com/ doi/full/10.1111/petr.13610 | 1.25 |
Mariam Elsherif | 2015 | MECOM gene overexpression in pediatric patients with acute myeloid leukemia | ACTA ONCOLOGICA | https://doi.org/10.1080/0284186X.2022.2025611 | 4.2 |
Programs | Start date | End date | No. of attendees | Affiliation |
Year 2014 | ||||
Pediatric Oncology Fellowship cohort 1 | 1-Nov-14 | Jul-17 | 4 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Year 2015 | ||||
Pediatric Oncology Fellowship cohort 2 | 1-Dec-15 | Jul-18 | 6 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Year 2016 | ||||
Pediatric Oncology Fellowship cohort 3 | 1-Dec-16 | Jul-19 | 6 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Year 2017 | ||||
Pediatric Oncology Fellowship cohort 4 | 1-Dec-17 | Jul-20 | 6 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Year 2018 | ||||
Pediatric Oncology Fellowship cohort 5 | 1-Dec-18 | Jul-21 | 6 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Year 2019 | ||||
Pediatric Oncology Fellowship cohort 6 | 1-Dec-19 | Ongoing | 4 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Year 2020 | ||||
Pediatric Oncology Fellowship cohort 7 | 1-Dec-20 | Ongoing | 4 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Year 2021 | ||||
Pediatric Oncology Fellowship cohort 8 | 1-Dec-21 | Ongoing | 4 | Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC) |
Pass Rate (No. of successful candidates / Total no of candidates): 100%